H. Jeffrey Wilkins, MD

Dr. H. Jeffrey Wilkins is the current Chief Medical Officer at Abcuro. H. has also previously served as the Chief Medical Officer at Lycera, Yaupon Therapeutics, Inc., and Zyla Life Sciences. In addition, they have also been a Partner at Nexeption and the Chief Clinical Advisor and CMO at Onspira Therapeutics, Inc. Prior to their current position, Dr. Wilkins served as the Senior Vice President of Clinical Development at Ception Therapeutics from 2006 to 2010.

Dr. H. Jeffrey Wilkins, MD is a medical doctor who attended Temple University's Lewis Katz School of Medicine. Prior to medical school, they completed a Bachelor of Science in Biology from Bucknell University.

A direct report to H. Jeffrey Wilkins, MD is and Jorge Escobar - VP Clinical Operations. They work with Steven A Greenberg - Chief Scientific Advisor and Chair, Medical Advisory Board, Dave Borbas - Research VP, Head of Data Management, and Kate Courtemanche - Chief Development Officer. Their manager is John Edwards, Executive Chair and Interim CEO.